Review began 06/24/2022 review ended 07/26/2022 published 08/04/2022 © copyright

HIGHLIGHTS

  • who: Report and collaborators from the Internal Medicine, Cleveland Clinic, Cleveland, USA have published the Article: Review began 06/24/2022 Review ended 07/26/2022 Published 08/04/2022 u00a9 Copyright, in the Journal: (JOURNAL) of August/04,/2022
  • what: The authors report a rare case of eosinophilic granulomatosis with polyangiitis (EGPA) with joint, skin, lung, and renal involvement shortly after beginning therapy with dupilumab.
  • future: Investigations and case reports are needed to strengthen the association and the underlying mechanism.

SUMMARY

    Dupilumab is a fully human IgG4 monoclonal . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?